nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trial
|
Lambin, Philippe |
|
1994 |
30 |
3 |
p. 312-320 9 p. |
artikel |
2 |
Amonafide as first-line chemotherapy for metastatic breast cancer
|
Kornek, G |
|
1994 |
30 |
3 |
p. 398-400 3 p. |
artikel |
3 |
Angiosarcoma of the breast following conserving treatment for breast cancer
|
Slotman, B.J. |
|
1994 |
30 |
3 |
p. 416-417 2 p. |
artikel |
4 |
Bioavailability of oral etoposide in gastric cancer
|
Taal, B.G. |
|
1994 |
30 |
3 |
p. 420-421 2 p. |
artikel |
5 |
Bone Marrow Transplantation
|
|
|
1994 |
30 |
3 |
p. 414- 1 p. |
artikel |
6 |
British Oncological Association
|
|
|
1994 |
30 |
3 |
p. 414- 1 p. |
artikel |
7 |
Clinical Hyperthermia
|
|
|
1994 |
30 |
3 |
p. 414- 1 p. |
artikel |
8 |
C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance
|
Warenius, Hilmar M. |
|
1994 |
30 |
3 |
p. 369-375 7 p. |
artikel |
9 |
Cytokines in clinical cancer treatment trials: Methodological aspects
|
Brennscheidt, U. |
|
1994 |
30 |
3 |
p. 412-414 3 p. |
artikel |
10 |
Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors
|
Chevalier, Thierry Le |
|
1994 |
30 |
3 |
p. 410-412 3 p. |
artikel |
11 |
ECCO 7
|
Purves, D. |
|
1994 |
30 |
3 |
p. 282-283 2 p. |
artikel |
12 |
Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: Frequency and prognostic significance
|
Passlick, B. |
|
1994 |
30 |
3 |
p. 376-381 6 p. |
artikel |
13 |
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus
|
Stahl, Michael |
|
1994 |
30 |
3 |
p. 325-328 4 p. |
artikel |
14 |
Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19
|
Mantovani, L.T. |
|
1994 |
30 |
3 |
p. 363-369 7 p. |
artikel |
15 |
Hellenic Biomedical Diaspora
|
|
|
1994 |
30 |
3 |
p. 414- 1 p. |
artikel |
16 |
How long have I got doctor?
|
Maher, E.J. |
|
1994 |
30 |
3 |
p. 283-284 2 p. |
artikel |
17 |
Human tumour bank in Croatia: a possible model for a small bank as part of the future European tumour bank network
|
Spaventi, Radan |
|
1994 |
30 |
3 |
p. 419- 1 p. |
artikel |
18 |
Immunomodulatory agents: the cytokines
|
Stein, R.C. |
|
1994 |
30 |
3 |
p. 400-404 5 p. |
artikel |
19 |
Inconsistent expression of HLA-B antigens on peripheral blood lymphocytes of stage I melanoma patients: an indicator of poor prognosis
|
Cascinelli, Natale |
|
1994 |
30 |
3 |
p. 294-298 5 p. |
artikel |
20 |
International microscopy and image analysis conference
|
|
|
1994 |
30 |
3 |
p. 414- 1 p. |
artikel |
21 |
Let's stop worrying about pigmented skin lesions in children
|
Bono, A. |
|
1994 |
30 |
3 |
p. 417- 1 p. |
artikel |
22 |
Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction—Single strand conformational polymorphism analysis and possible consequences in cancer cells
|
Touitou, Isabelle |
|
1994 |
30 |
3 |
p. 390-394 5 p. |
artikel |
23 |
N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment
|
Livingstone, A |
|
1994 |
30 |
3 |
p. 382-389 8 p. |
artikel |
24 |
Obesity and cancer risk: a danish record-linkage study
|
Møller, Henrik |
|
1994 |
30 |
3 |
p. 344-350 7 p. |
artikel |
25 |
Oncogenes and radiosensitivity
|
Cassoni, A.M. |
|
1994 |
30 |
3 |
p. 279-281 3 p. |
artikel |
26 |
Oral contraceptives and prognosis in breast cancer: Effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer
|
Holmberg, Lars |
|
1994 |
30 |
3 |
p. 351-354 4 p. |
artikel |
27 |
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases
|
Munck, Jean-Nicolas |
|
1994 |
30 |
3 |
p. 289-294 6 p. |
artikel |
28 |
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
|
O'Rourke, T.J. |
|
1994 |
30 |
3 |
p. 417-418 2 p. |
artikel |
29 |
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study
|
Holdener, Eduard E |
|
1994 |
30 |
3 |
p. 394-395 2 p. |
artikel |
30 |
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
|
Rosso, R |
|
1994 |
30 |
3 |
p. 338-343 6 p. |
artikel |
31 |
Prediction of survival in a hospital-based continuing care unit
|
Hardy, Janet R. |
|
1994 |
30 |
3 |
p. 284-288 5 p. |
artikel |
32 |
Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin
|
Durrant, L.G |
|
1994 |
30 |
3 |
p. 355-363 9 p. |
artikel |
33 |
Serum concentrations of cytokines in patients with Hodgkin's disease
|
Blay, Jean-Yves |
|
1994 |
30 |
3 |
p. 321-324 4 p. |
artikel |
34 |
Subsequent primary cancers following bladder cancer
|
Salminen, E. |
|
1994 |
30 |
3 |
p. 303-307 5 p. |
artikel |
35 |
Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy
|
Corona, R. |
|
1994 |
30 |
3 |
p. 333-338 6 p. |
artikel |
36 |
Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients
|
Helweg-Larsen, Susanne |
|
1994 |
30 |
3 |
p. 396-398 3 p. |
artikel |
37 |
Systemic treatment of colorectal cancer
|
Herrmann, R. |
|
1994 |
30 |
3 |
p. 404-409 6 p. |
artikel |
38 |
The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients
|
Railo, Mikael J. |
|
1994 |
30 |
3 |
p. 307-311 5 p. |
artikel |
39 |
The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2
|
Gore, M.E. |
|
1994 |
30 |
3 |
p. 329-333 5 p. |
artikel |
40 |
Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-α
|
Vuoristo, M. |
|
1994 |
30 |
3 |
p. 420- 1 p. |
artikel |
41 |
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer
|
Evans, W.K. |
|
1994 |
30 |
3 |
p. 299-303 5 p. |
artikel |
42 |
Why don't we use a “cavalieri”?
|
Bentzen, J.K.D. |
|
1994 |
30 |
3 |
p. 421-422 2 p. |
artikel |